FDA issued a Warning Letter to Sato Pharmaceutical Co., Ltd. on 2/2/2017 for a previous inspection.
483 Sato Pharmaceutical Jul 2018

483 Sato Pharmaceutical Jul 2018

Bonita Chester FDA, Steven Weinman FDA$119.00 - Available Now

FDA investigators audited the Sato Pharmaceutical - Hachioji, Japan facility and issued inspectional observations (via FDA 483) on 03 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Jul 2018
  • Location: Hachioji, Japan
  • FEI: 3004055563
Add To Cart